News

Partner companies' news

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
SAN JOSE, Calif. , April 6, 2022 /PRNewswire/ --  Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— April 2022 — 427 views ANIX

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis
HANOVER, MD, April 05, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— April 2022 — 423 views PCSA

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
CELEBRATION, Fla., March 30, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— April 2022 — 455 views KMPH

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
HANOVER, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage compa...
Acorn Management Partners, Administrator
— April 2022 — 427 views PCSA

Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
SAN JOSE, Calif. , March 30, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and...
Acorn Management Partners, Administrator
— April 2022 — 468 views ANIX

Luokung Announces Acquisition of Beijing Hongda Jiutong Technology Development Co., Ltd
BEIJING, March 29, 2022 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellige...
Acorn Management Partners, Administrator
— March 2022 — 458 views LKCO

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 478 views KMPH

Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing...
Acorn Management Partners, Administrator
— March 2022 — 420 views PCSA

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
CELEBRATION, Fla., March 21, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company or KemPharm), a specialty pharmaceutical company ...
Acorn Management Partners, Administrator
— March 2022 — 456 views KMPH

Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC
SAN JOSE, Calif. , March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— March 2022 — 488 views ANIX

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
CELEBRATION, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company, or KemPharm), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— March 2022 — 433 views KMPH

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— March 2022 — 438 views PCSA

KemPharm to Report Fourth Quarter and Full-Year 2021 Results
CELEBRATION, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

Medexus to Participate in the 34th Annual Roth Conference
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleas...
Acorn Management Partners, Administrator
— March 2022 — 486 views MEDXF

Medexus Pharmaceuticals Announces Deal for Gleolan in the United States
TORONTO and CHICAGO, March 01, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that it...
Acorn Management Partners, Administrator
— March 2022 — 454 views MEDXF

Luokung Affiliate eMapgo Provides Mapping Services for Ford Smart Vehicles
BEIJING, Feb.  23 , 2022 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intelli...
Acorn Management Partners, Administrator
— February 2022 — 429 views LKCO

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
CELEBRATION, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— February 2022 — 463 views KMPH

Luokung to Present at FORCE Family Office Webinar
BEIJING, Feb. 16, 2022 /PRNewswire/ --* Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellige...
Acorn Management Partners, Administrator
— February 2022 — 440 views LKCO

Medexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debentures
TORONTO and CHICAGO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the...
Acorn Management Partners, Administrator
— February 2022 — 451 views MEDXF

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
SAN JOSE, Calif., Jan. 25, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— January 2022 — 530 views ANIX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives